focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 110.50
Bid: 110.50
Ask: 111.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.905%)
Open: 110.50
High: 0.00
Low: 0.00
Prev. Close: 110.50
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Confirmation & Results of Exchange Offer

7 Dec 2022 07:00

RNS Number : 8271I
International Personal Finance Plc
07 December 2022
 

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the Republic of Ireland or in any other jurisdiction where it is unlawful to distribute this document.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.

SEE "IMPORTANT INFORMATION" BELOW

7 December 2022

International Personal Finance PLC (the "Issuer")

Sterling bonds: Final Terms Confirmation and Results of Exchange Offer

Summary:

·

holders of £37,605,200 of the Issuer's existing sterling notes due 14 December 2023 have elected to exchange them into the same amount of new 12 per cent. notes due 12 December 2027, pursuant to the exchange offer announced on 15 November 2022 (the "Exchange Offer"); and

·

an additional £12,394,800 of new notes will be issued for cash as Cash Offer New Notes (as defined below) (of which, £9,775,000 of Cash Offer New Notes will be retained in treasury by the Issuer, for possible sale in the future).

The net effect is:

·

prior to the Exchange Offer and new issue, the Issuer had £78,100,000 sterling notes maturing 14 December 2023;

·

once the Exchange Offer and new issue settle, the Issuer will have £40,494,800 sterling notes maturing 14 December 2023 and (excluding for these purposes those notes retained in treasury) £40,225,000 sterling notes maturing 12 December 2027, and will receive £2,619,800 of gross cash proceeds; and

·

the total size of the issue of New Notes (including those retained in treasury by the Issuer) is £50,000,000.

Commenting on this transaction, Gary Thompson, Chief Financial Officer, said: "We are pleased to have extended the maturity of over half of our sterling bonds a year ahead of maturity. The transaction supports our growth ambitions, ensuring that we continue to play an important role in society by building a better world through financial inclusion. I would like to thank our existing noteholders who extended and welcome our new noteholders."

Further details are as follows:

This announcement constitutes the Final Terms Confirmation Announcement referred to in (i) the Final Terms dated 15 November 2022 relating to the proposed issue by the Issuer of sterling-denominated 12 per cent. notes due 2027 for cash (the "Cash Offer New Notes Final Terms" and such notes being the "Cash Offer New Notes"); and (ii) the Final Terms contained in pages 51 to 61 of the Exchange Offer Memorandum dated 15 November (the "Exchange New Notes Final Terms" and the "Exchange Offer Memorandum") relating to the proposed offer for exchange of the Issuer's outstanding sterling-denominated 7.75 per cent. notes due 2023 (ISIN: XS1998163148) (the "Existing 2023 Notes") for 12 per cent. notes due 2027 ("Exchange New Notes").

This announcement also hereby announces the results of the Exchange Offer referred to in the Exchange Offer Memorandum. This announcement must be read in conjunction with, and as applicable, the Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) and the Cash Offer New Notes Final Terms (in all cases as defined above or below).

The Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) are available for viewing on the website of Kroll Issuer Services Limited (https://deals.is.kroll.com/ipfin). The Cash Offer New Notes Final Terms are available for viewing on the Issuer's website (https://www.ipfin.co.uk/en/investors/debt-funding-information.html).

The Offer Period relating to (i) the offer of Exchange New Notes, and (ii) the offer of Cash Offer New Notes, expired at 12 noon (London time) on 6 December 2022 and accordingly the Exchange New Notes and the Cash Offer New Notes (together, the "Notes") can no longer be subscribed for nor be obtained by way of application for exchange. Accordingly, this announcement is not an offer to subscribe, tender, sell or exchange any securities.

The Exchange New Notes and the Cash Offer New Notes to be issued will be consolidated and form a single series on 12 December 2022 (being the issue date), with ISIN XS2551486058 and Common Code 255148605.

The Issuer confirms the following for the purposes of this announcement:

Aggregate Nominal Amount of the Series of Notes to be issued:

£50,000,000 (of which, £37,605,200 are Exchange Offer New Notes and £12,394,800 are Cash Offer New Notes (which amount includes £9,775,000 being retained in treasury by the Issuer)).

Estimated net proceeds of the offer of the Series of Notes to be issued:

£39,621,625 (being the aggregate nominal amount of the New Notes (excluding those retained in treasury by the Issuer) at the issue price of 100 per cent. less the fees payable to the Dealer Manager in respect of both the issuance of the Cash Offer New Notes and the Exchange New Notes).

Estimated expenses relating to the offer of the Series of Notes to be issued:

£603,375 (being the fees payable to the Dealer Manager in relation to both the Exchange New Notes and the Cash Offer New Notes and deducted as described in estimated net proceeds of the offer of the Series of Notes to be issued above).

In relation to the Exchange Offer, the aggregate nominal amount of Existing 2023 Notes accepted for exchange by the Issuer is £37,605,200. Accordingly, the aggregate nominal amount of Existing 2023 Notes outstanding after the Exchange Offer will be £40,494,800.

- ENDS -

For further information, please contact:

International Personal Finance plc

Tom Crane (Company Secretary)

+44 (0)7594 513433

Rachel Moran (Investor Relations Manager)

+44 (0)7760 167637

IMPORTANT INFORMATION

This announcement is released by International Personal Finance PLC and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of Regulation (EU) 596/2014 as it forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended ("EUWA") ("UK MAR"), encompassing information relating to an exchange offer, as described above. For the purposes of UK MAR, this announcement is made by Tom Crane for International Personal Finance plc.

The distribution of this announcement and other information in connection with any offer of securities and/or the solicitation of offers for securities in certain jurisdictions may be restricted by law and persons who come into possession of this announcement or any document or other information referred to herein should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any securities. This announcement does not constitute and shall not, in any circumstances, constitute a public offering nor an invitation to the public in connection with any offer within the meaning of Regulation (EU) 2017/1129 (the "EU Prospectus Regulation") as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended (the "UK Prospectus Regulation"). Any offer and sale of any securities will be made in compliance with the requirements of the UK Prospectus Regulation.

Any securities referred to herein will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, such securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of, U.S. persons.

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFFIFRLRIIF
Date   Source Headline
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights
28th Mar 20233:40 pmRNSHolding in Company
22nd Mar 20234:19 pmRNSAnnual Report and Notice of AGM
17th Mar 20232:41 pmRNSDirector/PDMR Shareholding
13th Mar 20233:51 pmRNSDirector/PDMR Shareholding
7th Mar 20235:29 pmRNSHolding in Company
1st Mar 20237:00 amRNSFinal Results and Accounts
10th Feb 20234:40 pmRNSSecond Price Monitoring Extn
10th Feb 20234:35 pmRNSPrice Monitoring Extension
8th Feb 20238:35 amRNSDirector Declaration
25th Jan 20232:04 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSNotice of investor briefing - 18 January 2023
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSDirectorate Change
15th Dec 20224:35 pmRNSPrice Monitoring Extension
7th Dec 20227:00 amRNSFinal Confirmation & Results of Exchange Offer
2nd Dec 20224:50 pmRNSTotal Voting Rights
21st Nov 20224:35 pmRNSPrice Monitoring Extension
15th Nov 20223:44 pmRNSIPF Cash Offer Launch
15th Nov 20223:34 pmRNSIPF Exchange Offer
15th Nov 20223:27 pmRNSPublication of a Prospectus
11th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20229:53 amRNSNotice of investor briefing series
7th Nov 20227:00 amRNSRoadshow Announcement
4th Nov 20224:51 pmRNSPublication of Supplementary Prospectus
20th Oct 20227:00 amRNSQ3 2022 Trading Update
10th Oct 20224:41 pmRNSSecond Price Monitoring Extn
10th Oct 20224:35 pmRNSPrice Monitoring Extension
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
5th Oct 202210:27 amRNSTotal Voting Rights
27th Sep 20224:40 pmRNSSecond Price Monitoring Extn
27th Sep 20224:35 pmRNSPrice Monitoring Extension
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20224:40 pmRNSSecond Price Monitoring Extn
15th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20223:19 pmRNSHolding(s) in Company
6th Sep 20224:41 pmRNSSecond Price Monitoring Extn
6th Sep 20224:35 pmRNSPrice Monitoring Extension
1st Sep 202211:56 amRNSTotal Voting Rights
30th Aug 20224:08 pmRNS2022 AGM Vote - Update Statement
26th Aug 20224:21 pmRNSDirector/PDMR Shareholding
26th Aug 20229:00 amRNSPublication of a Prospectus
16th Aug 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.